abstract |
This invention relates to the addition of platelet activation inhibitors to solutions used in the pathogen reduction an subsequent storage of platelets. More particularly, the invention relates the addition of adenylate cyclase stimulators and phosphodiesterase inhibitors to a platelet pathogen reduction and storage solution. |